PETV vs. BTCY, MBOT, NXGL, SSKN, PSTV, NURO, GCTK, OSA, VAPO, and VVOS
Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include Biotricity (BTCY), Microbot Medical (MBOT), NEXGEL (NXGL), STRATA Skin Sciences (SSKN), Plus Therapeutics (PSTV), NeuroMetrix (NURO), GlucoTrack (GCTK), ProSomnus (OSA), Vapotherm (VAPO), and Vivos Therapeutics (VVOS). These companies are all part of the "surgical & medical instruments" industry.
Biotricity (NASDAQ:BTCY) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, valuation, community ranking, risk, analyst recommendations, earnings, dividends and profitability.
In the previous week, Biotricity had 2 more articles in the media than PetVivo. MarketBeat recorded 3 mentions for Biotricity and 1 mentions for PetVivo. PetVivo's average media sentiment score of 0.91 beat Biotricity's score of 0.00 indicating that Biotricity is being referred to more favorably in the media.
Biotricity has a beta of 1.54, meaning that its share price is 54% more volatile than the S&P 500. Comparatively, PetVivo has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500.
3.9% of Biotricity shares are owned by institutional investors. Comparatively, 24.6% of PetVivo shares are owned by institutional investors. 20.5% of Biotricity shares are owned by company insiders. Comparatively, 20.1% of PetVivo shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
Biotricity and PetVivo both received 0 outperform votes by MarketBeat users.
PetVivo has lower revenue, but higher earnings than Biotricity. Biotricity is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.
Biotricity has a net margin of -125.43% compared to Biotricity's net margin of -1,016.64%. PetVivo's return on equity of 0.00% beat Biotricity's return on equity.
Summary
Biotricity beats PetVivo on 7 of the 13 factors compared between the two stocks.
Get PetVivo News Delivered to You Automatically
Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
